The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long term follow-up (FU) of lenalidomide plus R-CHOP therapy in patients with newly diagnosed diffuse large b-cell lymphoma (DLBCL): Combined analysis from two phase 2 trials.
 
Alessia Castellino
No Relationships to Disclose
 
Betsy LaPlant
No Relationships to Disclose
 
Levi Pederson
No Relationships to Disclose
 
Annalisa Chiappella
Consulting or Advisory Role - Celgene; Janssen
Speakers' Bureau - Amgen; Celgene; Janssen; NanoString Technologies; Pfizer; Roche; Teva
 
Gianluca Gaidano
Honoraria - Gilead Sciences; Janssen; Karyopharm Therapeutics; MorphoSys; Novartis; Roche
Consulting or Advisory Role - Gilead Sciences; Janssen; Karyopharm Therapeutics; MorphoSys; Novartis; Roche
Speakers' Bureau - Janssen; Novartis; Roche
 
William R Macon
No Relationships to Disclose
 
Alessandra Tucci
No Relationships to Disclose
 
Rebecca L. King
No Relationships to Disclose
 
Angela Giovanna Congiu
No Relationships to Disclose
 
Thomas E. Witzig
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
Consulting or Advisory Role - Celgene; Seagen
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Novartis (Inst); Spectrum Pharmaceuticals (Inst)
 
Umberto Vitolo
Consulting or Advisory Role - Janssen; Roche
Speakers' Bureau - Celgene; Gilead Sciences; Janssen; Roche; Sandoz; Takeda
Research Funding - Celgene (Inst); Roche (Inst)
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene (Inst); Genentech (Inst); MorphoSys (Inst)
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)